DOCSLIB.ORG

Interaction, Function and Regulation of the Tight Junction Protein

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Interaction, Function and Regulation of the Tight Junction Protein Interaction, Function and Regulation of the Tight Junction Protein Tricellulin Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) Submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Jimmi David Cording from Lingen (Ems) 2015 The present thesis was realized in the research group Molecular Cell Physiology at the Leibniz-Institut für Molekulare Pharmakologie (FMP) in Berlin-Buch in the time scale from November 2008 until May 2015 under supervision of PD Dr Ingolf E. Blasig. 1. Gutachter: PD Dr. I. E. Blasig Leibniz-Institut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch Robert-Roessle-Str. 10 13125 Berlin 2. Gutachter: Prof. Dr. Volker Haucke Leibniz-Institut für Molekulare Pharmakologie (FMP) Campus Berlin-Buch Robert-Roessle-Str. 10 13125 Berlin Date of Disputation: 02.11.2015 Content Content 1 List of abbreviations .................................................................................. 4 2 Introduction .................................................................................................. 6 2.1 Organization and function of epithelium and endothelium ................................... 6 2.1.1 Tight junctions ................................................................................................ 8 2.2 Molecular composition of tight junctions .............................................................. 9 2.2.1 Claudins ........................................................................................................ 10 2.2.2 Tight junction associated MARVEL proteins .............................................. 13 2.2.3 Occludin ........................................................................................................ 14 2.2.4 Tricellulin ..................................................................................................... 15 2.2.5 MarvelD3 ...................................................................................................... 18 2.2.6 Tight junction-associated proteins ................................................................ 19 2.2.7 The Angulin-protein family .......................................................................... 20 2.3 Tight junction role in pathological events ........................................................... 21 2.3.1 Tight junctions during alterations of the Redox-state .................................. 22 3 Purpose and objectives .......................................................................... 24 4 Manuscript 1 ............................................................................................. 26 4.1 Synopsis ............................................................................................................... 27 4.2 Experimental contribution ................................................................................... 29 4.3 Manuscript 1 ........................................................................................................ 30 4.4 Supplemental material ..................................................................................... 5947 5 Manuscript 2 ............................................................................................. 51 5.1 Synopsis ............................................................................................................... 52 5.2 Experimental contribution ................................................................................... 53 5.3 Manuscript 2 ........................................................................................................ 54 5.4 Supplemental material ......................................................................................... 85 6 Manuscript 3 ............................................................................................. 69 6.1 Synopsis ............................................................................................................... 70 6.2 Experimental contribution ................................................................................... 72 6.3 Manuscript 3 ........................................................................................................ 72 6.4 Supplemental material ......................................................................................... 73 7 Manuscript 4 .............................................................................................. 88 7.1 Synopsis ............................................................................................................... 89 7.2 Experimental contribution ................................................................................... 91 7.3 Manuscript 4 ........................................................................................................ 92 7.4 Supplemental material ....................................................................................... 108 8 Discussion ................................................................................................. 110 8.1 Conclusion and outlook ..................................................................................... 122 9 Summary ................................................................................................... 124 9.1 Zusammenfassung .............................................................................................. 125 10 References ................................................................................................ 127 11 List of publications ................................................................................ 137 11.1 Enclosed in this thesis .................................................................................... 137 11.2 Other publications .......................................................................................... 137 11.3 Presentations at international meetings .......................................................... 138 12 Appendix ............................................................................................. 86139 12.1 Acknowledgements ........................................................................................ 139 3 List of abbreviations 1 List of abbreviations aa amino acid ATP adenosin-5´-triphosphat BBB blood-brain barrier bp base pair BSA bovine serum albumin bTJ bicellular tight junction CFP cyan fluorescent protein CK1 casein kinase 1 CK2 casein kinase 2 Cld claudin CRFR1 corticotropin-releasing factor receptor DAPI 4′,6-diamidin-2-phenylindol DMEM Dulbecco’s Modified Eagle Medium DNA desoxyribonucleic acid dNTP desoxyribonucleotid-5’-triphosphat E.coli Escherichia coli EDTA ethylendiamintetraacetat ER endoplasmatic reticulum FACS fluorescence activated cell sorting FCS fetal calf serum FRET fluorescence resonance energy transfer FRAP fluorescence recovery after photobleaching G418 geneticin GST gluthathion-S-transferase HA Human influenza hemagglutinin HEK human embryonic kidney cells IB immunblot IgG immunglobulin G IP co-Immunpräzipitation JAM junctional adhesion molecule MDCK madin-darby canine kidney cells MD3 marevelD3 MEM minimum essential medium Occl occludin PAGE polyacrylamidgel- electrophoresis PBS phosphate buffered saline PCR polymerase chain reaction PKA cAMP-dependent protein kinase PKC protein kinase C RNA ribonucleic acid RNAi RNA interference ROS reactive oxygen species RT room temperature SDS sodiumdodecylsulfate TEMED N, N, N', N'-Tetramethyethylendiamin TER transepithelial electric resistance TJ tight junctions Tric tricellulin Tris Tris (hydrocymethyl) aminoethan 4 List of abbreviations Triton-X100 t-Oktylphenoxypolyethoxyethanol tTJ tricellular tight junctions Tween20 Polyoxyethylensorbitanmonolaurat U units UV ultraviolet YFP yellow fluorescent protein ZO zonula occludens ZO-1 zonula occludens protein 1 5 Introduction 2 Introduction Multicellular organs rely on compartmentalization, to protect the body and to maintain homeostasis of the compartments, which is guaranteed by epithelial or endothelial cells. Organs, such as the uterus, ovaries, the brain and epidermis are all barrier containing tissues primarily intended to separate organ compartments (1). However, tissue barriers do not simply separate two distinct compartments or fluids; they provide protection against potentially harmful external agents and notably also arrange communication of neighboring cells. An essential feature of such barriers is represented by tissue-specific cellular junctions and cell-cell contacts, maintained and regulated by various multi protein complexes such as adherens junctions, gap junctions and tight junctions (TJs). A broad range of distinct disease conditions in humans is directly connected to alterations in epithelial or endothelial barrier properties. This may lead to a loss of stromal homeostasis and thereby affect fluid and electrolyte balance between compartments, within tumor microenvironment or generation of inflammatory states. Tumor progression or bacterial invasion through tissue barriers is accompanied by epithelial/endothelial barrier dysfunction or tightness modulation, often reflecting tumor- or pathogen-induced alterations of specific structures of these tissues, particularly of the TJs (1, 2). In these cases as in many other, pathological conditions, direct/indirect damage of tissue and TJs are found to relevantly contribute to disease progression. 2.1 Organization and function of epithelium and endothelium The four major tissue types are muscle, nerve, connective and epithelial tissues.
Load more

Recommended publications
  • MUC4/MUC16/Muc20high Signature As a Marker of Poor Prognostic for Pancreatic, Colon and Stomach Cancers
    Jonckheere and Van Seuningen J Transl Med (2018) 16:259 https://doi.org/10.1186/s12967-018-1632-2 Journal of Translational Medicine RESEARCH Open Access Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large‑scale genomic databases: MUC4/MUC16/ MUC20 signature is associated with poor survival in human carcinomas Nicolas Jonckheere* and Isabelle Van Seuningen* Abstract Background: MUC4 is a membrane-bound mucin that promotes carcinogenetic progression and is often proposed as a promising biomarker for various carcinomas. In this manuscript, we analyzed large scale genomic datasets in order to evaluate MUC4 expression, identify genes that are correlated with MUC4 and propose new signatures as a prognostic marker of epithelial cancers. Methods: Using cBioportal or SurvExpress tools, we studied MUC4 expression in large-scale genomic public datasets of human cancer (the cancer genome atlas, TCGA) and cancer cell line encyclopedia (CCLE). Results: We identifed 187 co-expressed genes for which the expression is correlated with MUC4 expression. Gene ontology analysis showed they are notably involved in cell adhesion, cell–cell junctions, glycosylation and cell signal- ing. In addition, we showed that MUC4 expression is correlated with MUC16 and MUC20, two other membrane-bound mucins. We showed that MUC4 expression is associated with a poorer overall survival in TCGA cancers with diferent localizations including pancreatic cancer, bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adeno- carcinoma, skin cancer and stomach cancer. We showed that the combination of MUC4, MUC16 and MUC20 signature is associated with statistically signifcant reduced overall survival and increased hazard ratio in pancreatic, colon and stomach cancer.
    [Show full text]
  • Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease
    Downloaded from http://cshperspectives.cshlp.org/ on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease Aaron Buckley and Jerrold R. Turner Departments of Pathology and Medicine (Gastroenterology), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115 Correspondence: [email protected] Mucosal surfaces are lined by epithelial cells. In the intestine, the epithelium establishes a selectively permeable barrier that supports nutrient absorption and waste secretion while preventing intrusion by luminal materials. Intestinal epithelia therefore play a central role in regulating interactions between the mucosal immune system and luminal contents, which include dietary antigens, a diverse intestinal microbiome, and pathogens. The paracellular space is sealed by the tight junction, which is maintained by a complex network of protein interactions. Tight junction dysfunction has been linked to a variety of local and systemic diseases. Two molecularly and biophysically distinct pathways across the intestinal tight junc- tion are selectively and differentially regulated by inflammatory stimuli. This review discusses the mechanisms underlying these events, their impact on disease, and the potential of using these as paradigms for development of tight junction-targeted therapeutic interventions. ucosal surfaces and the epithelial cells that adherens). The tight junction is a selectively Mline them are present at sites where tissues permeable barrier that generally represents the interface directly with the external environment rate-limiting step of paracellular transport. The or internal compartments that are contiguous adherens junction and desmosome provide es- with the external environment. Examples in- sential adhesive and mechanical properties that clude the gastrointestinal tract, the pulmonary contribute to barrier function but do not seal tree, and the genitourinary tract.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • A Functional Enrichment Test for Molecular Convergent Evolution Finds a Clear Protein-Coding Signal in Echolocating Bats and Whales
    A functional enrichment test for molecular convergent evolution finds a clear protein-coding signal in echolocating bats and whales Amir Marcovitza,1, Yatish Turakhiab,1, Heidi I. Chena,1, Michael Gloudemansc, Benjamin A. Braund, Haoqing Wange, and Gill Bejeranoa,d,f,g,2 aDepartment of Developmental Biology, Stanford University, Stanford, CA 94305; bDepartment of Electrical Engineering, Stanford University, Stanford, CA 94305; cBiomedical Informatics Program, Stanford University, Stanford, CA 94305; dDepartment of Computer Science, Stanford University, Stanford, CA 94305; eDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305; fDepartment of Pediatrics, Stanford University, Stanford, CA 94305; and gDepartment of Biomedical Data Science, Stanford University, Stanford, CA 94305 Edited by Scott V. Edwards, Harvard University, Cambridge, MA, and approved September 3, 2019 (received for review November 2, 2018) Distantly related species entering similar biological niches often parallel shifts in evolutionary rates in independent lineages of adapt by evolving similar morphological and physiological char- aquatic mammals (15). However, later analyses demonstrated that acters. How much genomic molecular convergence (particularly of the genome-wide frequency of molecular convergence in echolocating highly constrained coding sequence) contributes to convergent mammals is similar to the frequency in nonecholocating control phenotypic evolution, such as echolocation in bats and whales, is a outgroups,
    [Show full text]
  • Inducers of the Endothelial Cell Barrier Identified Through Chemogenomic Screening in Genome-Edited Hpsc-Endothelial Cells
    Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells Filip Roudnickya,1, Jitao David Zhang (张继涛)b,1,2, Bo Kyoung Kimc, Nikhil J. Pandyab, Yanjun Lana, Lisa Sach-Peltasond, Heloise Ragellec, Pamela Strassburgerc, Sabine Gruenerc, Mirjana Lazendicc, Sabine Uhlesc, Franco Revelantc, Oliv Eidamd, Gregor Sturmb, Verena Kueppersc, Klaus Christensena, Leonard D. Goldsteine, Manuel Tzourosb, Balazs Banfaib, Zora Modrusane, Martin Grafa, Christoph Patscha, Mark Burcina, Claas A. Meyera,3, Peter D. Westenskowc,2,3, and Chad A. Cowanf,g,h,2,3 aTherapeutic Modalities, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; bPharmaceutical Sciences, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; cOcular Technologies, Immunology, Infectious Diseases and Ophthalmology, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; dPharma Research and Early Development Informatics, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; eMolecular Biology Department, Genentech Inc., South San Francisco, CA 94080; fDivision of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; gDepartment of Stem Cell and Regenerative
    [Show full text]
  • Pediatric Hearing Loss and Cochlear Implant Update Disclosure
    3/27/2014 Pediatric Hearing Loss and Cochlear Implant Update David H. Chi, MD Children’s Hospital of Pittsburgh Medical Director, Hearing Center April 25, 2014 Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA Disclosure • Nothing to disclose Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA Learning Objectives 1. Review etiologies and various presentations of pediatric hearing loss. 2. Select appropriate workup and recognize findings that lead to a decision for cochlear implant. 3. Discuss surgery, plan of care, and the PA/NP role in followup for pediatric CI patients. Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA 1 3/27/2014 Why is early detection and treatment of sensorineural hearing loss so important? • Hearing loss is the most frequent birth condition. Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA Incidence per 10,000 of Congenital Defects/Diseases 40 30 30 20 12 11 10 6 5 2 1 0 Epidemiology • 1‐3 of 1,000 live births with moderate to severe hearing loss • Approximately 12,000 infants born annually in the U.S. with SNHI – 33 babies / day • 90% of deaf genetic kids / hearing parents Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA 2 3/27/2014 Why is early detection and treatment of sensorineural hearing loss so important? • Hearing loss is the most frequent birth condition • Undetected hearing loss has important negative consequences. Fourth Annual ENT for the PA-C | April 24-27, 2014 | Pittsburgh, PA Reading Comprehension Scores of Hearing and Deaf Students 10.0 9.0 8.0 7.0 6.0 Deaf 5.0 Hearing 4.0 3.0 2.0 1.0 Grade Equivalents 8 9 10 11 12 13 14 15 16 17 18 Age in Years Schildroth, A.
    [Show full text]
  • Zeb1 Modulates Hematopoietic Stem Cell Fates Required for Suppressing Acute Myeloid Leukemia
    The Journal of Clinical Investigation RESEARCH ARTICLE Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia Alhomidi Almotiri,1,2 Hamed Alzahrani,1 Juan Bautista Menendez-Gonzalez,1 Ali Abdelfattah,1 Badi Alotaibi,1 Lubaid Saleh,1 Adelle Greene,1 Mia Georgiou,1 Alex Gibbs,1 Amani Alsayari,1 Sarab Taha,1 Leigh-anne Thomas,1 Dhruv Shah,1, Sarah Edkins,3 Peter Giles,3 Marc P. Stemmler,4 Simone Brabletz,4 Thomas Brabletz,4 Ashleigh S. Boyd,5,6 Florian A. Siebzehnrubl,1 and Neil P. Rodrigues1 1European Cancer Stem Cell Research Institute, Cardiff University, School of Biosciences, Cardiff, United Kingdom. 2College of Applied Medical Sciences-Dawadmi, Shaqra University, Dawadmi, Saudi Arabia. 3Wales Gene Park and Wales Cancer Research Centre, Division of Cancer and Genetics, Cardiff University, School of Medicine, Cardiff, United Kingdom. 4Department of Experimental Medicine 1, Nikolaus- Fiebiger-Center for Molecular Medicine, FAU University Erlangen-Nürnberg, Erlangen, Germany. 5Department of Surgical Biotechnology, Division of Surgery and Interventional Science, Royal Free Hospital, and 6Institute of Immunity and Transplantation, University College London, London, United Kingdom. Zeb1, a zinc finger E-box binding homeobox epithelial-mesenchymal transition (EMT) transcription factor, confers properties of “stemness,” such as self-renewal, in cancer. Yet little is known about the function of Zeb1 in adult stem cells. Here, we used the hematopoietic system as a well-established paradigm of stem cell biology to evaluate Zeb1-mediated regulation of adult stem cells. We employed a conditional genetic approach using the Mx1-Cre system to specifically knock out (KO) Zeb1 in adult hematopoietic stem cells (HSCs) and their downstream progeny.
    [Show full text]
  • A Novel Unbiased Test for Molecular Convergent Evolution And
    bioRxiv preprint first posted online Jul. 31, 2017; doi: http://dx.doi.org/10.1101/170985. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY-NC 4.0 International license. Title A novel unbiased test for molecular convergent evolution and discoveries in echolocating, aquatic and high-altitude mammals Amir Marcovitz1, Yatish Turakhia2, Michael Gloudemans3, Benjamin A. Braun4, Heidi I. Chen1 & Gill Bejerano1,4,5,6 1 Department of Developmental Biology, Stanford University, Stanford, California, 94305, USA 2 Department of Electrical Engineering, Stanford University, Stanford, California, 94305, USA 3 Biomedical Informatics Program, Stanford University, Stanford, CA 94305, USA 4 Department of Computer Science, Stanford University, Stanford, California 94305, USA 5 Department of Pediatrics, Stanford University, Stanford, California 94305, USA 6 To whom correspondence should be addressed at [email protected] Keywords convergent evolution, genome wide tests, echolocation, aquatic, high altitude, subterranean, mammals 1 bioRxiv preprint first posted online Jul. 31, 2017; doi: http://dx.doi.org/10.1101/170985. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY-NC 4.0 International license. Abstract Distantly related species entering similar biological niches often adapt by evolving similar morphological and physiological characters. The extent to which genomic molecular convergence, and the extent to which coding mutations underlie this convergent phenotypic evolution remain unknown. Using a novel test, we ask which group of functionally coherent genes is most affected by convergent amino acid substitutions between phenotypically convergent lineages.
    [Show full text]
  • Gnomad Lof Supplement
    1 gnomAD supplement gnomAD supplement 1 Data processing 4 Alignment and read processing 4 Variant Calling 4 Coverage information 5 Data processing 5 Sample QC 7 Hard filters 7 Supplementary Table 1 | Sample counts before and after hard and release filters 8 Supplementary Table 2 | Counts by data type and hard filter 9 Platform imputation for exomes 9 Supplementary Table 3 | Exome platform assignments 10 Supplementary Table 4 | Confusion matrix for exome samples with Known platform labels 11 Relatedness filters 11 Supplementary Table 5 | Pair counts by degree of relatedness 12 Supplementary Table 6 | Sample counts by relatedness status 13 Population and subpopulation inference 13 Supplementary Figure 1 | Continental ancestry principal components. 14 Supplementary Table 7 | Population and subpopulation counts 16 Population- and platform-specific filters 16 Supplementary Table 8 | Summary of outliers per population and platform grouping 17 Finalizing samples in the gnomAD v2.1 release 18 Supplementary Table 9 | Sample counts by filtering stage 18 Supplementary Table 10 | Sample counts for genomes and exomes in gnomAD subsets 19 Variant QC 20 Hard filters 20 Random Forest model 20 Features 21 Supplementary Table 11 | Features used in final random forest model 21 Training 22 Supplementary Table 12 | Random forest training examples 22 Evaluation and threshold selection 22 Final variant counts 24 Supplementary Table 13 | Variant counts by filtering status 25 Comparison of whole-exome and whole-genome coverage in coding regions 25 Variant annotation 30 Frequency and context annotation 30 2 Functional annotation 31 Supplementary Table 14 | Variants observed by category in 125,748 exomes 32 Supplementary Figure 5 | Percent observed by methylation.
    [Show full text]
  • CARACTERÍSTICAS ESTRUTURAIS E FUNCIONAIS DAS CÉLULAS ENDOTELIAIS: Revisão Da Literatura
    UNIVERSIDADE FEDERAL DE GOIÁS ESCOLA DE VETERINÁRIA E ZOOTECNIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIA ANIMAL SEMINARIOS APLICADOS CARACTERÍSTICAS ESTRUTURAIS E FUNCIONAIS DAS CÉLULAS ENDOTELIAIS: Revisão da Literatura Juliana Carvalho de Almeida Borges Orientador: Eugênio Gonçalves de Araújo GOIÂNIA 2011 JULIANA CARVALHO DE ALMEIDA BORGES CARACTERÍSTICAS ESTRUTURAIS E FUNCIONAIS DAS CÉLULAS ENDOTELIAIS: Revisão da Literatura Seminário apresentado junto à Disciplina Seminários Aplicados do Programa de Pós-Graduação em Ciência Animal da Escola de Veterinária e Zootecnia da Universidade Federal de Goiás Nível: Mestrado Área de concentração: Patologia, Clínica e Cirurgia Animal Linha de Pesquisa: Patobiologia animal, experimental e comparada Orientador: Prof. Dr. Eugênio Gonçalves de Araújo – EVZ/UFG Comitê de Orientação: Profª. Drª. Veridiana Maria Brianezi Dignani de Moura – EVZ/UFG Drª. Yandra Cassia Lobato do Prado – EVZ/UFG GOIÂNIA 2011 ii SUMÁRIO 1. INTRODUÇÃO................................................................................................... 1 2. REVISÃO DA LITERATURA............................................................................. 2 2.1 Características estruturais das células endoteliais.................................... 2 2.1.1 A descoberta da célula endotelial............................................................. 2 2.1.2 Morfologia da célula endotelial................................................................. 3 2.1.3 Especializações da membrana da célula endotelial...............................
    [Show full text]
  • Germline Variants That Influence the Tumor Immune Microenvironment Also Drive Response to Immunotherapy
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.14.436660; this version posted April 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Germline variants that influence the tumor immune microenvironment also drive response to immunotherapy Authors: Meghana Pagadala1, Victoria H. Wu4, Eva Pérez-Guijarro12, Hyo Kim15, Andrea Castro2, James Talwar2, Cristian Gonzalez-Colin3, Steven Cao5, Benjamin J. Schmiedel3, Rany M. Salem5, Gerald P. Morris6, Olivier Harismendy7,10, Sandip Pravin Patel8, Jill P. Mesirov9,10, Maurizio Zanetti10,11, Chi-Ping Day12, Chun Chieh Fan13, Wesley K. Thompson14, Glenn Merlino12, J. Silvio Gutkind4, Pandurangan Vijayanand3, Hannah Carter9,10,* *Correspondence to: [email protected] Affiliations: 1Biomedical Science Program, University of California San Diego, La Jolla, CA 92093, USA 2Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, 92093, USA 3La Jolla Institute for Immunology, La Jolla, CA, 92037, USA 4Department of Pharmacology, UCSD Moores Cancer Center, La Jolla, CA, 92093, USA 5Division of Epidemiology, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, 92093, USA 6Department of Pathology, University of California San Diego, La Jolla, CA 92093, USA 7Division of Biomedical Informatics, Department of Medicine, University of California San Diego School of Medicine, La Jolla,
    [Show full text]
  • Tight Junctions As a Key for Pathogens Invasion in Intestinal Epithelial Cells
    International Journal of Molecular Sciences Review Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells Tracy Paradis 1, Hervé Bègue 1, Louise Basmaciyan 1,2, Frédéric Dalle 1,2,* and Fabienne Bon 1 1 UMR PAM l’Université de Bourgogne Franche-Comté (UBFC), AgroSup Dijon, Equipe Vin, Aliment, Microbiologie, Stress, F21000 Dijon, France; [email protected] (T.P.); [email protected] (H.B.); [email protected] (L.B.); [email protected] (F.B.) 2 Laboratoire de Parasitologie-Mycologie, Plateforme de Biologie Hospitalo-Universitaire Gérard Mack, F21000 Dijon, France * Correspondence: [email protected]; Tel.: +33-3-8029-5014 Abstract: Tight junctions play a major role in maintaining the integrity and impermeability of the intestinal barrier. As such, they act as an ideal target for pathogens to promote their translocation through the intestinal mucosa and invade their host. Different strategies are used by pathogens, aimed at directly destabilizing the junctional network or modulating the different signaling pathways involved in the modulation of these junctions. After a brief presentation of the organization and modulation of tight junctions, we provide the state of the art of the molecular mechanisms leading to permeability breakdown of the gut barrier as a consequence of tight junctions’ attack by pathogens, including bacteria, viruses, fungi, and parasites. Keywords: enterocytes; gut barrier; tight junction; intestinal epithelial cells; pathogens; microorgan- Citation: Paradis, T.; Bègue, H.; isms; signaling pathways; permeability Basmaciyan, L.; Dalle, F.; Bon, F. Tight Junctions as a Key for Pathogens Invasion in Intestinal Epithelial Cells. Int.
    [Show full text]